title: What is the optimal time to estimate the final vascular response to a drug-eluting stent by optimal coherence tomography?
authors.affiliation: Division of Cardiovascular Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, College of Medicine.
authors.forename: Yoon-Seok
authors.initials: YS
authors.lastname: Koh
authors.forename: Sang Hong
authors.initials: SH
authors.lastname: Baek
mesh_terms: D020341:Absorbable Implants / Q000009:adverse effects*; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D000068338:Everolimus; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents; D008297:Male; D058426:Neointima / Q000453:epidemiology*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects*; D020123:Sirolimus / Q000031:analogs & derivatives*
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus